Aethlon Medical, Inc. Key Metrics

2 years of history · ending 2025-03-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Working Capital Analysis

Valuation Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-9
Book Value Per Share
$3
Free Cash Flow Per Share
$-5
Cash Per Share
$4
Revenue Per Share
$0
OCF Per Share
$-5
Return on Equity
-245.9%
Return on Assets
-171.6%
Return on Invested Capital
-135.5%
Current Ratio
3.13
Quick Ratio
3.13
Asset Turnover
0.00
Days Sales Outstanding
R&D / Revenue
SBC / Revenue
Capex / Revenue
Working Capital
$4M
Net Current Asset Value
$4M
Invested Capital
$5M
OCF / Net Income
0.57
FCF / Net Income
0.57
Accruals Ratio (Sloan)
-78.0%
Net Debt
$-6M
Net Debt / EBITDA
0.61
Interest Coverage
-924.06
Cash Coverage
-756.31
Capex Coverage
-40.38
Tangible Common Equity
$5M
TCE / Total Assets
69.6%
NOPAT
$-7M
Cash ROIC
-140.4%
WC / Revenue
Capex / D&A
0.00
Reinvestment Rate
3.6%
Total Payout Ratio
Asset Growth vs Revenue Growth
47.1%
Revenue 5Y CAGR
Book Value 5Y CAGR
-11.2%
Stock Price (FY-end)
$29
Market Cap
$45M
P/S Ratio
P/B Ratio
8.77
P/TB Ratio
8.77
Enterprise Value
$39M
EV / Sales
FCF Yield
-17.0%
Shareholder Yield
-0.9%
R&D Yield
4.9%
Capex Yield
0.0%
Shares Variation (YoY)
396.9%
Beta (5Y)
0.81
Cost of Equity
8.5%
52W High
$141
52W Low
$21
Trailing Return 1Y
-78.9%
Trailing Return 5Y
-97.6%
F-Score (Piotroski)
1.00
Z-Score (Altman)
-20.45

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Stock Price on Earnings Dates